Effect of embryo culture media on birthweight and length in singleton term infants after IVF-ICSI. by Wunder, D. et al.
Original article | Published 8 October 2014, doi:10.4414/smw.2014.14038
Cite this as: Swiss Med Wkly. 2014;144:w14038
Effect of embryo culture media on birthweight and
length in singleton term infants after IVF-ICSI
Dorothea Wundera, Pierluigi Ballabenib, Matthias Roth-Kleinerc, Marie-Pierre Primia, Alfred Sennd, Alain Chansond, Marc Germondd,
Celine Leyvraza
a Reproductive Medicine, Department of Obstetrics and Gynaecology, Lausanne University Hospital, Lausanne, Switzerland
b Institute of Social and Preventive Medicine (IUMSP), Lausanne University Hospital, Lausanne, Switzerland
c Clinic of Neonatology, Lausanne University Hospital, Lausanne, Switzerland
d Private Centre for Reproductive Medicine, CPMA, Lausanne, Switzerland
Summary
QUESTIONS UNDER STUDY: To investigate if two dis-
tinct, commercially available embryo culture media have a
different effect on birthweight and length of singleton term
infants conceived after IVF-ICSI.
METHODS: University hospital based cohort study.
Between 1 January 2000 and 31 December 2004, patients
conceiving through IVF-ICSI at the University Hospital,
Lausanne have been allocated to two distinct embryo cul-
ture media. Only term singleton pregnancies were analysed
(n = 525). Data analysis was performed according to two
commercially available culture media: Vitrolife® (n = 352)
versus Cook® (n = 173). Analysis was performed through
linear regression adjusted for confounders. Media were
considered equivalent if the 95% confidence interval lay
between –150 g/+150 g.
RESULTS: Length, gestational age and distribution of
birthweight percentiles did not differ between groups (for
both genders). Analysis of the whole cohort, adjusted for a
subset of confounders, resulted in a statistically not differ-
ent mean birthweight between the two groups (Vitrolife®
+37 g vs Cook®, 95%CI: –46 g to 119 g) suggesting equi-
valence. Adjustment for an enlarged number of con-
founders in a subsample of patients (n = 258) also revealed
no relevant mean birthweight difference of +71 g (95%CI:
–45 g to 187 g) in favour of Vitrolife®; however, lacking
power to prove equivalence.
CONCLUSIONS: Our data suggest that significant differ-
ences in birthweight due to these two distinct, commer-
cially available embryo culture media are unlikely.
Key words: Embryo culture medium; birthweight;
perinatal outcome; IVF; ICSI; human
Introduction
Since the introduction of in vitro fertilisation (IVF) – in-
tracytoplasmatic sperm injection (ICSI), several studies
have shown that birthweight of infants conceived after
fresh IVF-ICSI cycles is lower than birthweight of
neonates after spontaneous conception, even in singleton
pregnancies [1, 2]. The reasons for these differences still
remain uncertain. Many different aspects are taken into
consideration, such as intrinsic effects of the patients (in-
fertility, age, smoking etc.), hormonal stimulation of the
ovaries or the effects of the treatment itself, i.e., in-vitro
culture which may cause imprinting disorders and epigen-
etic changes.
In 2010, Dumoulin et al. postulated that specific culture
media could be a predisposing factor of inferior birth-
weight [3]. They compared in a non-randomised, retro-
spective cohort study the effect of two different commer-
cially available culture media on the outcome of singleton
pregnancies after fresh IVF-ICSI cycles and observed that
neonates, cultured as embryos in the Cook® embryo culture
media, had lower birthweight compared to those of the
Vitrolife® culture media. In a second retrospective cohort
study (same time frame as the first study and including
partly the same cohort), they analysed the effect of these
two culture media on frozen cycles and twin pregnancies
and did not find any significant difference in birthweight,
although a trend in the same direction was observed [4].
When analysing the same patient group in a third retro-
spective cohort study, they found that differences in in-
trauterine growth could be detected as early as the second
trimester [5]. A very recently published Norwegian study,
comparing birthweight after embryo culture in three differ-
ent media with birthweight after spontaneous conception,
showed significant differences in birthweight and also in
placental weight in relation to birthweight [6]. However,
other research groups, investigating the same and other
commercialised culture media, could not find any differen-
ces in birthweight related to the use of varying embryo cul-
ture media [7–10]. Unfortunately, the exact composition of
the culture media is a manufacturing secret of the differ-
ent companies producing embryo culture media. Only the
type of ingredients can be found out, not the precise com-
position. As epigenetic modifications can occur already
during the first days of the embryonic life, it would be
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thinkable that some ingredients (or concentrations of in-
gredients), present in one culture medium, but not in anoth-
er, could modify birthweight by influencing epigenetic pro-
cesses and could result accordingly in higher respectively
lower birthweight. Research on this topic is therefore very
important.
Hence, there are many unanswered questions on this theme
and the debate is ongoing. As birthweight is an important
predictor for long-term health implications, it is primordial
to ascertain if there is an association between specific cul-
ture media and adverse fetal outcomes with potentially
long lasting consequences in adulthood.
In the current study, we investigated birthweight of
singleton term infants after culture in embryo culture media
from the same distributors (Vitrolife and Cook) as Du-
moulin et al. and Carrasco et al. [3, 10]. The primary ob-
jective was to evaluate and compare birthweight and length
of singleton term newborn infants, conceived after IVF-
ICSI (fresh and frozen cycles) and cultured in two distinct,
widely used commercial culture media systems (Vitrolife®
and Cook®). We tested the hypothesis that both culture me-
dia are equivalent with respect to birthweight and length.
Material and methods
Patients, study design and data collection
All patients who underwent IVF-ICSI fresh or frozen treat-
ment cycles at the University Hospital of Lausanne
(CHUV) from 1 January 2000 to 31 December 2004 and
had singleton live births at term were considered for the
study. Additional inclusion criteria were age ≤43 years,
pre-treatment hormonal values in the normal range and
normal gynaecological ultrasound and cervical smear. Ex-
clusion criteria for an IVF/ICSI-treatment were acute or
chronic infectious diseases (patient and/or her partner),
severe psychiatric illness, or known carrier of a severe ge-
netic disease.
To sum up, in an IVF-ICSI fresh cycle, stimulation of sev-
eral follicles in the ovaries is undertaken until maturation
of at least three follicles is seen by ultrasound, with cor-
responding oestradiol levels. On the day of oocyte retriev-
al, the sperm is prepared in the IVF-laboratory and mature
oocytes are fertilised either by IVF or ICSI. The next day,
supernumerary fertilised oocytes at the pronuclei stage are
cryopreserved; one or two are cultured until embryo trans-
fer (two or three days after oocyte pick-up). Quantitative
pregnancy test is undertaken 14 days after embryo transfer.
A total of 525 patients fulfilled the inclusion criteria; 352
had embryos cultured in Vitrolife® media and 173 in
Cook® media. Only healthy neonates were included. In-
fants with major congenital malformations or genetic de-
fects were excluded. All included cycles were cycles with
own gametes and without gestational carrier (according to
the Swiss law). ICSI was performed in the case of male in-
fertility or if less than five oocytes could be obtained.
Patients were addressed to one of the two laboratory sites,
one using culture media from Vitrolife® (Vitrolife AB,
Goteborg, Sweden) and the other from Cook® (Cook Med-
ical, Brisbane, Australia), in order not to be dependent on
only one distributor. Separation of the laboratory in two
sites was undertaken for space and organisational reasons.
The only difference between the two laboratory sites was
the embryo culture medium. Otherwise, the setting (labor-
atory and medical staff, laboratory equipment and proced-
ures, stimulation protocols etc.) was the same. At the site
using Vitrolife® culture media, more IVF-ICSI cycles were
performed, explaining the difference in the number of new-
borns between the two groups. Attribution to one or the
other site was randomly performed and followed practical
and not medical reasons (availability of consultation space,
accessibility, insurance reasons etc.). However, it was not
performed following a clear randomisation protocol.
Measurements of weight and length of newborn infants
were obtained through the local IVF-ICSI registry (col-
lection of the data by medical reports). Anthropometric
measurements were performed in both centres by trained
nurses and midwives in accordance to the methods de-
scribed by Cheik Ismail et al. [11]. The attitude was not dif-
ferent in the measurements between the two groups. The
birthweight of each newborn infant was adjusted for gest-
ational age/gender and attribution to growth percentiles
and growth categories was performed. Factors influencing
neonatal birthweight, such as parental weight and height
measurements, smoking habits and complications during
pregnancy were collected by contacting the patients. Due
to the fact, that the latter information was collected by a
questionnaire sent to the parents and return rate was not a
100%, all birthweight adjustments could not be undertaken
for the whole study population. Thus, two analyses were
performed separately: one within the whole study popula-
tion and the other in the sample with the complete data set
based on the additional information of the filled in ques-
tionnaires.
The study was approved by the institutional ethical com-
mittee.
Ovarian stimulation regimens
The “long” stimulation protocol was used for controlled
ovarian hyperstimulation. Downregulation was performed
with the agonist Triptorelin, 0.1 mg per day SC; for ovarian
stimulation recombinant FSH was administered SC. To as-
sess follicular maturation, ultrasound and serum oestradiol
measurements were carried out. Selection criteria for ovu-
lation induction included at least three follicles exceeding
17 mm in diameter and an oestradiol concentration per ma-
ture follicle exceeding 1000 pmol/l. Ovulation induction
was performed with 5000 to 10000 IU hCG and 35 to
36 hours later, the follicular fluid with the oocytes was
retrieved from all follicles by needle aspiration. Oocyte
pick-up (OPU) was performed with transvaginal ultrasound
guidance and under routine general anaesthesia.
The transfer of the embryos was performed two days after
the OPU; only in the case of week-ends, the transfer was
performed three days after the OPU. As embryo cryop-
reservation in Switzerland is forbidden by law, elective
single embryo transfer could not be performed.
Vaginal progesterone was used to support the luteal phase.
In the case of a cryocycle, oestradiol in form of tablets or
patches was used (artificial cycles), in order to promote a
sufficient endometrial thickness (>7 mm).
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Two weeks after the transfer, a quantitative pregnancy test
was performed. In the event of pregnancy, support of the
luteal phase was continued until nine weeks of gestation.
The first obstetric ultrasound was performed four weeks
after embryo transfer.
In-vitro fertilisation laboratory protocol
Cumulus-oocyte complexes were incubated in fertilisation
medium K-SIFM (Sydney IVF Fertilization Medium,
Cook®, Brisbane, Australia) or IVF (IVF Science Scand-
inavia, part of Vitrolife® group, Goteborg, Sweden) imme-
diately after OPU. On day 1 (16–18 hours post insemina-
tion with conventional IVF or ICSI), oocytes were checked
for the presence of two pronuclei and two polar bodies.
One to three of them were then transferred to a new four-
well dish [12, 13] with either culture medium K-SICM
(Sydney IVF Cleavage Medium, Cook® Brisbane, Aus-
tralia), corresponding in our study to the Cook®-group or
IVF (same medium as for insemination, Vitrolife® Gote-
borg, Sweden) corresponding to Vitrolife study group, until
embryonic transfer on day 2 (day 3 in the case of week-
ends). The zygotes were cultured in a CO2 incubator with
5% O2 (CYTOPERM 2, HERAUS, Thermo Fisher
Scientific Inc.). The other oocytes were cryopreserved at
pronuclei stage according to conventional slow freezing
protocol adopted from Lassalle et al. [14]. The freezing
and thawing solutions were made by mixing cryoprotect-
ants with Human Tubal Fluid (HTF) medium (University
Hospital, Lausanne, Switzerland) containing Synthetic Ser-
um Substitute (SSS) (Irvine Scientific, Santa Ana, USA).
Briefly, zygotes were incubated for 15 minutes at room
temperature in a freezing solution containing 1.5 M PrOH
(1,2-propanediol) (SIGMA-ALDRICH, St. Louis, USA)
and 0.1 M sucrose (SIGMA-ALDRICH, St. Louis, USA),
then loaded in plastic straws (CryoBioSystem, St. Ouens,
France) and placed in an automated freezer (Minicool
40PC, Carbagas, Switzerland). They were further thawed
with cryoprotectants (1.0 M PrOH and 0.2 M sucrose); re-
moval in three steps. Embryo culture and embryo transfer
were performed as in fresh cycles, on day 2 (or day 3). Cul-
ture conditions were 37 °C, 6% O2 and 6% CO2.
Statistical analysis
The effect of culture medium on birthweight was estimated
by means of linear least square regression adjusted for
the confounding factors. Our primary objective was to test
whether both culture media are equivalent in terms of mean
birthweight. In an equivalence test, one tries to reject the
null hypothesis saying a difference exists which is larger
than a pre-defined maximum irrelevant difference. We con-
sidered a mean birthweight difference up to 150 g as being
clinically insignificant because it represents less than 5% of
mean birthweight of term neonates and <10% of the normal
variation between term born at 37 and 42 weeks of gest-
ation (for newborn females: percentile [P]10%: 2,500 g,
P90%: 4,200 g; for newborn males: P10%: 2,550 g, P90%:
4350 g) [15]. Thus, in the present study, for a two-sided
test with alpha = 0.05, the null hypothesis will be rejected,
and both culture media are to be considered as equivalent,
if the 95% confidence interval of the regression’s coeffi-
cient will lie completely within the interval (–150 g, 150 g).
The regression coefficient estimates the mean birthweight
difference between culture media. A power calculation was
performed prior to data collection. Statistical power was
calculated to be 79% to detect equivalence between 352
Vitrolife and 173 Cook embryos, with a maximum toler-
ated difference of 150 g, standard deviation of 550 g in
each group [3], and alpha of 5%.
The effect of culture medium on birthweight was adjusted
in a multiple linear regression by the sex of the infants, type
of IVF-cycle (fresh versus frozen), gestational age, height
and weight of mother and father, mother’s smoking status
(smoker versus non-smokers), maternal age, multiparity
(multiparous versus primiparous) and pregnancy complica-
tions (yes versus no).
Birthlength was compared between culture media using the
same methods as for birthweight.
Further characteristics of parents and infants were com-
pared between culture media by means of t-tests (quantit-
ative, normally distributed variables), chi-square tests (cat-
egorical variables with cell frequencies >4) or Fisher’s ex-
act tests for categorical variables with cell frequencies <5).
The statistical package Stata version 12 (StataCorp LP,
College Station, USA) was used for the analyses.
Results
Analysis of the whole patient sample
Data from 525 patients who delivered singleton infants at
term were analysed. Among them, 352 had embryos cul-
tured in Vitrolife® media and 173 in Cook® media. The
characteristics of the male and female newborns are shown
in table 1. Weight, length, gestational age and birthweight
percentiles did not differ between the groups for both
genders. The distribution of these parameters is presented
in figure 1. Again, no significant differences were ob-
served, although a trend to higher percentage of births
between 38 and 39 weeks of gestation is to be noted in the
Cook® group.
After adjustment for infant sex, gestational age and type of
IVF-cycle, analysis of the whole study population suggests
the two culture media being equivalent regarding their ef-
fect on birthweight, since the confidence interval lies com-
Figure 1
Distribution of birthweight, birthlength, percentiles of birthweight
and exact gestational age at birth of the two distinct groups.
V = Vitrolife®; C = Cook®.
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pletely within the equivalence boundary (fig. 2). The same
regression model could not provide enough evidence of an
effect of cycle type (fresh versus frozen) on neonatal birth-
weight (frozen cycle averaging 2.2 g less than fresh cycles,
95% CI from –75.3 to –79.8 g).
No evidence for a difference in birthlength between culture
media was found. After adjustment for infant sex, gesta-
tional age and type of IVF-cycle, Vitrolife® children were
in the average 0.06 cm longer than Cook® children (fig. 3).
As for birthweight, our data do not provide sufficient evid-
ence that cycle type results in differential birthlength (mean
difference in the adjusted model: 0.07 cm in favour of the
fresh cycle: 95% CI from –0.25 to 0.39 cm).
Analysis of the patient sample with complete data set
In half of the patients (175/352 [49.7%] in the Vitrolife®
group; 83/173 [47.9%] in the Cook® group), additional in-
formation was obtained by a secondarily filled in ques-
tionnaire. The characteristics of these patients with com-
Figure 2
Birthweight. Regression coefficients of the adjusted and unadjusted
models with 95% confidence intervals. The whole sample was
adjusted for infant sex, gestational age and type of IVF-cycle. The
sample with complete data was adjusted for sex of the infants, type
of IVF-cycle, gestational age, height and weight of parents,
mother’s smoking status maternal age, multiparity and pregnancy
complications. The coefficients represent the mean birth weight
difference between culture media. The dashed lines represent the
equivalence limits.
Figure 3
Birthlength. Regression coefficients of the adjusted and unadjusted
models with 95% confidence intervals. The coefficients represent
the mean birthlength difference between culture media. See legend
of figure 2 for the details about the adjustments.
plete data set are shown in table 2. Maternal and paternal
as well as IVF-ICSI-treatment characteristics did not differ
between the groups. Significant differences could not be
found concerning neonatal characteristics, either (table 2).
The mean raw birthweight for the term infants was 3,355.7
g (±476 g) in the Vitrolife® group and 3,229.1 g (±499 g)
in the Cook® group, corresponding to a mean weight dif-
ference of 127 g, with 95%CI ranging from ‒0.15 to 253 g
(fig. 2). After adjustment for the confounding variables, the
mean difference between the two culture media groups was
71 g in favour of Vitrolife®, with 95%CI ranging from –45
to 187 g (fig. 2). The interaction between sex and medium
was also analysed and no significant difference was found
(interaction 95%CI: –273.3 g to 197.6 g). The variance in
the data, however, did not allow to prove the equivalence
of the two culture media. The same regression model did
not provide sufficient evidence that cycle type (fresh versus
frozen) had an effect on birthweight (mean difference 24.5
g in favour of fresh cycle, 95%CI: –83.9 to 131.9 g).
In conclusion, birthweight of term newborns was not sig-
nificantly different in the two groups, although a trend to-
wards higher weight was found in the Vitrolife® group.
Cycle type (fresh or frozen) had no impact on birthweight.
No conclusive evidence for a difference in birthlength
between culture media was found (fig. 3). Before adjust-
ment for the confounding factors, Vitrolife® children were
in the average 0.44 cm longer than Cook® children, with
95%CI ranging from –0.11 to 0.99. After adjustment, the
difference remained in favour of Vitrolife®, but with smal-
ler amplitude (mean difference: 0.24 cm; 95%CI from
–0.23 to 0.71 cm). Again, our data provide no evidence for
a difference in birthlength between cycle types (mean dif-
ference 0.07 cm in favour of fresh cycle, with 95%CI from
–0.36 to 0.50).
Birthweight distribution
Even though not influencing mean birthweight of a study
population, culture media could have an impact by increas-
ing percentage of small and/or large for gestational age in-
fants, meaning more newborn infants below P10 or above
P90. We therefore analysed birthweight distribution (fig.
1A) in relation to birthweight according to birthweight per-
centile categories (fig. 1B) and gestational age (fig. 1C).
There were no differences between the two groups, partic-
ularly, in the percentage of small for gestational age infants
(fig. 1B), according to the two clinical definitions of small
for gestational age infants (birthweight below P3 and be-
low P10).
Discussion
The present study explores the embryo culture media from
the same distributors as Dumoulin et al. and Carrasco et
al. [3, 10]. These two groups presented very different study
results, Dumoulin et al. showing a significantly increased
birthweight (+ 245 g) after culture in Vitrolife® media com-
pared to Cook® media, while Carrasco et al. could not find
any differences, either in the retrospective or in the pro-
spective arm of their study.
Our results suggest that there is no statistically significant
difference of birthweight after embryo culture in Vitrolife®
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or Cook® media. In the overall study population adjusted
for infant’s sex and gestational age, data showed equi-
valence of the two culture media regarding birthweight.
Considering only those patients in which a complete data
set was available, permitting adjustment also for maternal
risk factors and paternal growth parameters, equivalence
of the two culture media could not be shown anymore, as
this patient group was underpowered for detecting equi-
valence between culture media. Therefore, the adjusted
whole-sample analysis suggesting equivalence has to be
taken with care because bias due to insufficient adjustment
for confounders cannot be excluded. Indeed, the adjusted
complete-data analysis (fig. 2) suggests a mean difference
of 71 g between the two groups, representing only a trend
to higher birthweight in the Vitrolife® group. In accordance
with the study by Lin et al., we neither found a significant
difference in length [9]. Unfortunately, the latter item was
not evaluated in the Dumoulin study.
Besides their potential effect on mean birthweight differen-
ces, culture media could impact fetal growth by favouring
high risk growth alterations, meaning a higher percentage
of small or large for gestational age infants. However, our
data did not show either a significant difference in the num-
ber of low for gestational age infants (P3 or P10) between
the two groups, or in the number of large for gestational age
infants (P90 or P97) (fig. 1B).
A further important finding of this study is that there is
no difference in birthweight between the two culture me-
dia, if fresh and frozen cycles are regarded separately. It
is worth noting that neonatal birthweight after fresh IVF
Table 1: Neonatal outcome of live born term singletons (whole sample).
Vitrolife® Cook® P-value
Number of singletons 352 173
Fresh cycles (%) 191 (54.3) 93 (53.8) 0.91a
Frozen cycles (%) 161 (45.7) 80 (46.2) 0.91a
Gestational age (weeks) 39.4 (1.1) 39.2 (1.2) 0.12b
Average weight newborn (g) 3,315 (476) 3,250 (479) 0.15b
Average weight female newborn (g) 3,284 (429) 3,215 (476) 0.23b
Average weight male newborn (g) 3,349 (520) 3,290 (482) 0.39b
Average height newborn (cm) 49.5 (2.0) 49.3 (2.1) 0.37b
Average height female newborn (cm) 49.3 (1.7) 48.8 (2.0) 0.05b
Average height male newborn (cm) 49.7 (2.2) 49.9 (2.1) 0.55b
Low birth weight (<2500 g) 16 (4.5) 7 (4.0) 0.79a
High birth weight (>4500 g) 2 (0.6) 2 (1.2) 0.60c
Small for gestational age (<10th percentile) 55 (15.7) 26 (15.1) 0.86a
Very small for gestational age (<3th percentile) 15 (4.3) 11 (6.4) 0.30a
Large for gestational age (90–97th percentile) 15 ( 4.3) 4 ( 2.3) 0.28a
Very large for gestational age (>97th percentile) 7 (2.0) 5 (2.9) 0.53a
Data are mean (± SD) or n (%).
a Chi-squared test; b Two-tailed t-test for independent samples; c Fisher's exact test.
Table 2: Characteristics of the patients with complete data.
Vitrolife® Cook® P-value
Number of patients (%) 175 (49.7) 83 (48.0) 0.71a
Maternal characteristics
Age of the patients (years) 33.7 (3.8) 34.5 (4.5) 0.13b
Height (cm) 166.9 (6.14) 167.6 (6.27) 0.41b
Weight (kg) 62.9 (10.4) 61.8 (10.2) 0.43b
BMI (kg/m2) 22.6 (3.47) 22.0 (3.01) 0.16b
Smoking 30 (17.1) 11 (13.2) 0.42a
Multiparity 14 (8.0) 12 (14.5) 0.11a
Complications during pregnancy (%)
Arterial hypertension 4 (2.3) 3 (3.6) 0.68c
Gestational diabetes 1 (0.6) 1 (1.2) 0.54c
Paternal characteristics
Height (cm) 178.1 (6.44) 179.4 (6.35) 0.13b
Weight (kg) 79.2 (11.2) 79.0 (10.4) 0.91b
BMI (kg/m2) 25.0 (2.91) 24.5 (2.55) 0.27b
IVF-ICSI treatment characteristics
Fresh cycles (%) 93 (53.1) 44 (53.0) 0.98a
Frozen cycles 82 (46.9) 39 (47.0) 0.98
Newborn characteristics
Gestational age (weeks) 39.5 (1.06) 39.3 (1.15) 0.21b
Weight (g) 3,355.7 (475.64) 3,229.1 (498.97) 0.05b
Height (g) 49.6 (2.01) 49.2 (2.13) 0.10b
Data are mean (SD) or n (%).
a Chi-squared test; b Two-tailed t-test for independent samples; c Two-tailed Fisher's exact test.
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cycles was not significantly different when compared to
neonatal birthweight after frozen cycles, in contrast to the
literature [16]. A hypothesis to explain this latter contrast-
ing finding could be that in Switzerland, due to legal re-
strictions, freezing is performed at the stage of a fertilised
oocyte with two pronuclei and two polar bodies, and not at
the embryonic stage.
The published studies concerning the influence of culture
media on birthweight are quite difficult to compare because
of different study designs and research questions. For ex-
ample, in their recently published trial, Carrasco et al. in-
cluded a study arm with prospective randomisation of 98
term and preterm singleton live births after culture in Vitro-
life® or Cook® media following fresh IVF-ICSI cycles
[10]. However, Dumoulin et al. included in their first retro-
spective study singleton pregnancies already at >20 weeks
gestation after fresh IVF-ICSI cycles, 110 after culture with
Vitrolife® medium and 78 with Cook® and so comparing a
wider range of gestational age neonates [3]. Furthermore,
their second retrospective study comprised singleton preg-
nancies of >20 weeks gestation after frozen cycles (22
after culture with Vitrolife® medium and 45 with Cook®)
as well as 20, respectively 24 twin pregnancies following
fresh IVF-ICSI cycles [4]. On the other hand, Eaton et
al. explored, in their retrospective study, fresh IVF-ICSI
cycles with day 3 transfer after culture with three other
culture media (G1.3®, Global® and G1.5®), and analysing
singletons with gestational age >34 weeks [8]. In the same
year, Vergouw et al. published a retrospective study includ-
ing singletons >22 weeks gestation after fresh IVF-ICSI
cycles with day 3 transfer and frozen cycles with day 5
transfer, after culture with again two disparate culture me-
dia, namely HTF® and Sage Quinn’s advantage protein®
[7]. A retrospective Chinese study compared birthweight
of singletons and twins >20 weeks gestation after IVF-
ICSI fresh cycles and culture with, yet again, distinct cul-
ture media (G5™ ®, Global® and Quinn’s advantage pro-
tein®) and day 3 transfer [9]. A retrospective observational
study, investigating again 3 other culture media (Medicult
ISM1®, n = 402; Vitrolife G-1 PLUS®, n = 449; and Medi-
cult Universal®, n = 1,584), showed mean birthweights of
3,352 g, 3441 g and 3,448 g, respectively, the correspond-
ing mean placental weights were 693 g, 704 g and 684 g,
respectively. Due to the high numbers included, these min-
imal differences in birthweight between the groups (i.e.,
7 g to maximal 96 g) were statistically significant [6].
Lastly, the most recently published study from the Du-
moulin group, analysing again a cohort of 265 singletons,
found that growth velocity and head circumference were
similar between the two groups, but growth differences
persisted (weight measurements were not shown, only
standard deviation scores). A reason for caution and lim-
itation of this study is that they did not correct for factors
influencing post-natal growth (i.e., childhood diseases, nu-
trition, etc.) [17].
The question if day 2 versus day 3 transfer could influence
birthweight is completely unclear until today. The studies
published on birthweight differences are very heterogen-
eous, some including newborns after 2 days of culture [10],
others including newborns after 2 and 3 days of culture
[3–5], again others including newborns after 3 days of
culture [8, 9], and once again others including newborns
after 3 days and 5 days of culture [7]. In summary, most
studies did not find any birthweight difference between
the different culture media, even though embryos were
in one study group cultured until 5 days. However, the
group of Dumoulin showed birthweight differences after
only 2 and 3 days of culture (however, no difference noted
between 2 versus 3 days). More data are available in lit-
erature concerning differences in viability and outcome of
day 2 versus day 3 embryos. With culture duration, the risk
of arrested embryos rises, which is in general due to aneu-
ploidy. Several randomised controlled trials have been con-
ducted in order to find out if it would be preferable to trans-
fer the embryos on day 2 or day 3 and a Cochrane analysis
has been done [18]. In this systematic review, the authors
found no evidence to suggest a significant improvement in
live birth when delaying embryo transfer from day 2 to day
3.
Whether a difference is statistically significant or not is
among other things a question of numbers. However, more
important than the statistical significance may be the clin-
ical relevance. Today, it is difficult to conclude that the
significant respectively not significant differences in birth-
weight are clinically relevant. However, considering the
Barker hypothesis, it could be very possible that a few
days in a certain environment as an embryo could have
an impact in later life and an adverse environmental influ-
ence on the embryo by in-vitro culture as a cause of car-
diovascular and cardiometabolic dysfunction has already
been hypothesised [19, 20]. Yet, it should be emphasised
that IVF-ICSI is an extremely complex process and many
different factors, besides the utilisation of different com-
mercialised culture media, the known parental clinical con-
founding factors and underlying parental genetic factors,
could have repercussions on epigenetic processes of the in-
fants and might potentially influence their outcome: dif-
ferent laboratory techniques, culture length (2 days versus
5 days), culture conditions (percent of oxygen concentra-
tion), etc. The complexity of this issue highlights how dif-
ficult it is to have comparable study results.
One of the strengths of the present study is the homogenous
study population: we included only full term births after a
singleton pregnancy. Another one is its sample size, being
amongst the largest to analyse Vitrolife® and Cook® culture
media, despite the fact that only full term births were in-
cluded. Even though, as a drawback of this study, it is not
a properly prospective randomised study, allocation to the
one or the other culture medium has been done randomly,
depending on the site of the laboratory to which the patient
was addressed. Both laboratories have been located in the
same city and within a distance of one kilometre, excluding
a geographical bias. As the same laboratory staff worked
on both sites, potential biases caused by different laborat-
ory techniques, equipments and protocols can also be ex-
cluded in this study.
In conclusion, the present study results show neither a sig-
nificant difference in birthweight and length of singleton
term newborn infants after IVF-ICSI treatment comparing
the two embryo culture media Vitrolife® and Cook®, nor a
significant difference in the number of low for gestational
Original article Swiss Med Wkly. 2014;144:w14038
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age infants (P3 or P10) respectively large for gestational
age infants (P90 or P97) between the two groups.
Further research is required, in order to elucidate the im-
pact of embryo culture media and other aspects of the cul-
ture system that may be associated with adverse outcomes
on the health of children conceived by IVF-ICSI.
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Figures (large format)
Figure 1
Distribution of birthweight, birthlength, percentiles of birthweight and exact gestational age at birth of the two distinct groups.
V = Vitrolife®; C = Cook®.
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Figure 2
Birthweight. Regression coefficients of the adjusted and unadjusted models with 95% confidence intervals. The whole sample was adjusted for
infant sex, gestational age and type of IVF-cycle. The sample with complete data was adjusted for sex of the infants, type of IVF-cycle,
gestational age, height and weight of parents, mother’s smoking status maternal age, multiparity and pregnancy complications. The coefficients
represent the mean birth weight difference between culture media. The dashed lines represent the equivalence limits.
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Figure 3
Birthlength. Regression coefficients of the adjusted and unadjusted models with 95% confidence intervals. The coefficients represent the mean
birthlength difference between culture media. See legend of figure 2 for the details about the adjustments.
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